The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU Hematology & Medical Oncology Review 2019
C

KU ASCO 2019 Review of SCLC, Early & Locally Advanced NSCLC: Year of Neoadjuvant Therapy and Checkpoint Inhibitors

By KU Hematology & Medical Oncology Review 2019 FEATURING Corey Langer
By KU Hematology & Medical Oncology Review 2019 FEATURING Corey Langer
1,609 views
August 2, 2019
1 Comment
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
Lung
15:47
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Review of SCLC, Early & Locally Advanced NSCLC: Yea…

Feat. C. Langer
22:33
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Review of Recurrent / Metastatic NSCLC: Wild Type, KN00…

Feat. C. Langer